Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients
about
Increased aminoglycoside dosage requirements in hematologic malignancy.Gentamicin pharmacokinetics, nephrotoxicity, and prediction of mortality in febrile neutropenic patientsProspective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin.
P2860
Q35253342-8FF9474D-0A49-48B7-BC46-2643B14C75FCQ35359054-98E30504-B932-44E1-B4AA-779CF82FD8CFQ35573306-9CE8F9D3-8D70-449C-96E6-09C6625A4B20Q38090988-47E4CED5-CCCE-431B-B7B0-E0839D38302EQ39616905-7EC9EC9F-7B81-4771-AE34-30586F109222Q39828374-3711B4E9-17D1-45C3-B60B-D722BAA410F7Q50530085-821A9643-8530-4D62-8BA9-F02AF6120F6D
P2860
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Comparison of standard versus ...... anulocytopenic cancer patients
@ast
Comparison of standard versus ...... anulocytopenic cancer patients
@en
type
label
Comparison of standard versus ...... anulocytopenic cancer patients
@ast
Comparison of standard versus ...... anulocytopenic cancer patients
@en
prefLabel
Comparison of standard versus ...... anulocytopenic cancer patients
@ast
Comparison of standard versus ...... anulocytopenic cancer patients
@en
P2093
P2860
P356
P1476
Comparison of standard versus ...... anulocytopenic cancer patients
@en
P2093
Fortner CL
Schimpff SC
Wiernik PH
deJongh CA
P2860
P304
P356
10.1128/AAC.22.2.193
P407
P577
1982-08-01T00:00:00Z